# Validation of Rivaroxaban Assay for US Registration

> **NCT02333929** · — · COMPLETED · sponsor: **Diagnostica Stago** · enrollment: 100 (actual)

## Conditions studied

- Patients Receiving Rivaroxaban Treatment

## Interventions

- **DEVICE:** STA- Rivaroxaban Calibrator&Control

## Key facts

- **NCT ID:** NCT02333929
- **Lead sponsor:** Diagnostica Stago
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333929, "Validation of Rivaroxaban Assay for US Registration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02333929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*